tiprankstipranks
Trending News
More News >

OpenAI Biotechnology Profile - TipRanks - OpenAI Analyst

11 Followers
tipranks
OpenAI Biotechnology

OpenAI Biotechnology
TipRanks - OpenAI

Wall Street Analyst
#11,871 out of 12,135 Wall Street Analysts
#39,880 out of 44,390 experts

Success Rate

44%
202 out of 455 ratings made a profit

Average Return

-7.20%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying OpenAI Biotechnology's trades since 2024 and holding each position for 1 Year would result in 44.40% of your transactions generating a profit, with an average return of -7.2% per rating.

Stock Rating Distribution

21KRatings
74.11% Hold
19.13% Sell
6.76% Buy
Distribution of OpenAI Biotechnology's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States
Australia
Canada
France
Hong Kong
United Kingdom
Spain

Best Rating

Stock:
3SBio, Inc.
(1530)
Rating:Buy
Date:Apr 20, 2025 - Jul 04, 2025
Return:+299.00%
The most profitable rating made by OpenAI Biotechnology

OpenAI Biotechnology's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
ADXS
Advaxis
Nov 13, 2024
Sell
Initiated
1Ratings
0.00%
TCON
TRACON Pharmaceuticals
Nov 13, 2024
Sell
Initiated
1Ratings
0.00%
XTL Biopharmaceuticals Sponsored ADR
Nov 13, 2024
Sell
Initiated
1Ratings
0.00%
VBIVQ
VBI Vaccines
Nov 13, 2024
Sell
Initiated
1Ratings
0.00%
Sigyn Therapeutics
Nov 13, 2024
Sell
Initiated
1Ratings
0.00%
Seelos Therapeutics
Nov 14, 2024
Sell
Initiated
1Ratings
0.00%
LBPH
Longboard Pharmaceuticals
Nov 14, 2024
Hold
Initiated
1Ratings
0.00%
EXAI
Exscientia Plc
Nov 18, 2024
Sell
Downgraded
2Ratings
0.00%
Notable Labs
Nov 20, 2024
Sell
Reiterated
2Ratings
0.00%
ONCT
Oncternal Therapeutics
Nov 26, 2024
Sell
Reiterated
3Ratings
0.00%
List of latest recommendations made by OpenAI Biotechnology. Click to expand and see OpenAI Biotechnology's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

OpenAI Biotechnology activity FAQ

What is the performance of OpenAI Biotechnology's recommendations?
The percentage of profitable recommendations made by OpenAI Biotechnology is 44%, and the average return per transaction is -7.20%.
    What stocks does OpenAI Biotechnology cover?
    OpenAI Biotechnology mostly covers SGMO ,CAPR ,TSE:APLI stocks.
      What was OpenAI Biotechnology's most profitable rating?
      OpenAI Biotechnology’s most profitable ratings was a buy on HK:1530 stock on Apr 20, 2025 - Jul 04, 2025. The return on the trade was +299.00%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here